FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Bolger

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jinxia Deng; Tino Sanchez; Laith Q Al-Mawsawi; Raveendra Dayam; Rosendo A Yunes; Antonio Garofalo; Michael B Bolger; Nouri Neamati
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
Daryl L Davies; L D McCauley; Michael B Bolger; Ronald L Alkana
Pressure-sensitive and -insensitive coupling in gamma-aminobutyric acid(A) receptors.
Michael B Bolger; Stephen Swenson; Francis S Markland
Three-dimensional structure of fibrolase, the fibrinolytic enzyme from southern copperhead venom, modeled from the X-ray structure of adamalysin II and atrolysin C.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Bolger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Jinxia Deng; Tino Sanchez; Laith Q Al-Mawsawi; Raveendra Dayam; Rosendo A Yunes; Antonio Garofalo; Michael B Bolger; Nouri Neamati
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
Bioorganic & medicinal chemistry 2007;15(14):4985-5002.
2001: Daryl L Davies; L D McCauley; Michael B Bolger; Ronald L Alkana
Pressure-sensitive and -insensitive coupling in gamma-aminobutyric acid(A) receptors.
Psychopharmacology 2001;157(4):401-10.
2001: Michael B Bolger; Stephen Swenson; Francis S Markland
Three-dimensional structure of fibrolase, the fibrinolytic enzyme from southern copperhead venom, modeled from the X-ray structure of adamalysin II and atrolysin C.
AAPS pharmSci 2001;3(2):E16.
1999: Vincent H L Lee; C Chu; Denny Mahlin; SK Basu; David K Ann; Michael B Bolger; Ian S Haworth; AK Yeung; Sharon K Wu; Sarah F Hamm-Alvarez; Curtis T Okamoto
Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1.
Journal of controlled release : official journal of the Controlled Release Society 1999;62(1-2):129-40.
1999: Daryl L Davies; Michael B Bolger; Roberta Diaz Brinton; Deborah A Finn; Ronald L Alkana
In vivo and in vitro hyperbaric studies in mice suggest novel sites of action for ethanol.
Psychopharmacology 1999;141(4):339-50.
1998: Michael B Bolger; Ian S Haworth; AK Yeung; David K Ann; Hermann von Grafenstein; Sarah F Hamm-Alvarez; Curtis T Okamoto; Kwang-Jin Kim; SK Basu; S Wu; Vincent H L Lee
Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1.
Journal of pharmaceutical sciences 1998;87(11):1286-91.
1998: SK Basu; Ian S Haworth; Michael B Bolger; Vincent H L Lee
Proton-driven dipeptide uptake in primary cultured rabbit conjunctival epithelial cells.
Investigative ophthalmology & visual science 1998;39(12):2365-73.
1998: AK Yeung; SK Basu; Sharon K Wu; C Chu; Curtis T Okamoto; Sarah F Hamm-Alvarez; Hermann von Grafenstein; Wei-Chiang Shen; Kwang-Jin Kim; Michael B Bolger; Ian S Haworth; David K Ann; Vincent H L Lee
Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton- coupled dipeptide transporter (hPepT1).
Biochemical and biophysical research communications 1998;250(1):103-7.
1996: Michael B Bolger; S Wieland; Jon E Hawkinson; H Xia; RB Upasani; NC Lan
In vitro and in vivo activity of 16,17-dehydro-epipregnanolones: 17,20-bond torsional energy analysis and D-ring conformation.
Pharmaceutical research 1996;13(10):1488-94.
1996: Daryl L Davies; M Bejanian; E S Parker; Jørg Mørland; Michael B Bolger; Roberta Diaz Brinton; Ronald L Alkana
Low level hyperbaric antagonism of diazepam's locomotor depressant and anticonvulsant properties in mice.
The Journal of pharmacology and experimental therapeutics 1996;276(2):667-75.
1994: Jon E Hawkinson; C L Kimbrough; L D McCauley; Michael B Bolger; NC Lan; Kelvin W Gee
The neuroactive steroid 3 alpha-hydroxy-5 beta-pregnan-20-one is a two-component modulator of ligand binding to the GABAA receptor.
European journal of pharmacology 1994;269(2):157-63.
1992: F S Lee; Z T Chu; Michael B Bolger; Arieh Warshel
Calculations of antibody-antigen interactions: microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603.
Protein engineering 1992;5(3):215-28.
1992: Kelvin W Gee; NC Lan; Michael B Bolger; S Wieland; Delia Belelli; J S Chen
Pharmacology of a GABAA receptor coupled steroid recognition site.
Advances in biochemical psychopharmacology 1992;47():111-7.
1991: NC Lan; Kelvin W Gee; Michael B Bolger; J S Chen
Differential responses of expressed recombinant human gamma-aminobutyric acidA receptors to neurosteroids.
Journal of neurochemistry 1991;57(5):1818-21.
1991: NC Lan; Michael B Bolger; Kelvin W Gee
Identification and characterization of a pregnane steroid recognition site that is functionally coupled to an expressed GABAA receptor.
Neurochemical research 1991;16(3):347-56.
1991: Michael B Bolger; M A Sherman
Computer modeling of combining site structure of anti-hapten monoclonal antibodies.
Methods in enzymology 1991;203():21-45.
1989: Deborah L Johnson; M Nichols; Michael B Bolger; S Wilson
Interaction of yeast transcription factor IIIC with dimeric Schizosaccharomyces pombe tRNA(Ser)-tRNA(Met) genes.
The Journal of biological chemistry 1989;264(32):19221-7.
1989: Delia Belelli; Michael B Bolger; Kelvin W Gee
Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one.
European journal of pharmacology 1989;166(2):325-9.
1988: Darwin S Linthicum; Michael B Bolger; P H Kussie; G M Albright; T A Linton; S Combs; D Marchetti
Analysis of idiotypic and anti-idiotypic antibodies as models of receptor and ligand.
Clinical chemistry 1988;34(9):1676-80.
1988: Kelvin W Gee; Michael B Bolger; R E Brinton; H Coirini; B S McEwen
Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
The Journal of pharmacology and experimental therapeutics 1988;246(2):803-12.
1988: M A Sherman; Michael B Bolger
Haloperidol binding to monoclonal antibodies. Predictions of three-dimensional combining site structure via computer modeling.
The Journal of biological chemistry 1988;263(9):4064-74.
1988: M A Sherman; R J Deans; Michael B Bolger
Haloperidol binding to monoclonal antibodies. Hypervariable region amino acid sequence determination.
The Journal of biological chemistry 1988;263(9):4059-63.
1986: M A Sherman; Darwin S Linthicum; Michael B Bolger
Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
Molecular pharmacology 1986;29(6):589-98.
1985: Michael B Bolger; K Flurkey; R D Simmons; Darwin S Linthicum; P Laduron; M Michiels
Preparation and characterization of antisera and monoclonal antibodies to haloperidol.
Immunological investigations 1985;14(6):523-40.
1985: Darwin S Linthicum; Michael B Bolger
Using molecular mimicry to produce anti-receptor antibodies.
BioEssays : news and reviews in molecular, cellular and developmental biology 1985;3(5):213-7.
1985: K Flurkey; Michael B Bolger; Darwin S Linthicum
Preparation and characterization of antisera and monoclonal antibodies to serotonergic and dopaminergic ligands.
Journal of neuroimmunology 1985;8(2-3):115-27.